• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴基斯坦开伯尔-普赫图赫瓦省研究和诊断实验室生物风险管理系统的横断面调查。

A Cross-Sectional Survey to Assess Biorisk Management System in Research and Diagnostic Laboratories in Khyber Pakhtunkhwa, Pakistan.

机构信息

Department of Microbiology, University of Haripur, Haripur, Pakistan.

Department of Microbiology, University of Health Sciences Lahore and Technical Advisor, Health Security Partners, Lahore, Pakistan.

出版信息

Front Public Health. 2021 Dec 17;9:766162. doi: 10.3389/fpubh.2021.766162. eCollection 2021.

DOI:10.3389/fpubh.2021.766162
PMID:34976925
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8718442/
Abstract

Financial, cultural, and managerial hurdles have made biosafety and biosecurity measures difficult in resource-constrained countries like Pakistan. Because of increasing awareness of biorisk management, diagnostic and research laboratories have made major advances in biosafety and biosecurity in the recent decade. As a result, identifying and addressing gaps in biorisk management has never been more critical. The purpose of this study was to assess the current situation of personal protective equipment (PPE), biosafety behavior, waste management, biosafety and biosecurity measures, training and safety, and health services in diagnostic and research laboratories across Pakistan's Khyber Pakhtunkhwa (KP) province. We adapted the WHO Laboratory Assessment tool (2012) and CWA 15793 (Biorisk management guidelines) for conducting a cross-sectional survey, which was distributed among various laboratories in KP. The survey included 30 laboratories, including 11 diagnostic and 19 research laboratories. In comparison to diagnostic laboratories, biorisk management practices in research laboratories were better in terms of PPE, biosafety behavior, waste management, biosafety measures, biosecurity measures, trainings, and safety and health services. KP laboratories' biorisk management practices have improved over time, according to our findings. However, we were able to identify inadequacies that would require considerable improvements to the current setups based on the WHO and CWA 15793 recommendations. Organizations can tailor their biosafety measures and training to address identified gaps using the presented KP snapshot.

摘要

在巴基斯坦等资源有限的国家,财政、文化和管理方面的障碍使得生物安全和生物安保措施难以实施。由于人们对生物风险管理的认识不断提高,诊断和研究实验室在最近十年中在生物安全和生物安保方面取得了重大进展。因此,确定和解决生物风险管理方面的差距从未如此重要。本研究旨在评估巴基斯坦开伯尔-普赫图赫瓦省(KP)各地诊断和研究实验室的个人防护设备(PPE)、生物安全行为、废物管理、生物安全和生物安保措施、培训和安全以及卫生服务的现状。我们改编了世界卫生组织的实验室评估工具(2012 年)和 CWA 15793(生物风险管理指南),以进行横断面调查,该调查在 KP 的各个实验室中进行了分发。该调查包括 30 个实验室,其中包括 11 个诊断实验室和 19 个研究实验室。与诊断实验室相比,研究实验室在 PPE、生物安全行为、废物管理、生物安全措施、生物安保措施、培训以及安全和卫生服务方面的生物风险管理实践更好。根据我们的发现,KP 实验室的生物风险管理实践随着时间的推移而有所改善。然而,根据世界卫生组织和 CWA 15793 的建议,我们能够确定需要对当前设置进行重大改进的不足之处。各组织可以根据所呈现的 KP 快照,调整其生物安全措施和培训,以解决已确定的差距。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/8718442/1a635e644b67/fpubh-09-766162-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/8718442/5fc9b894b3d2/fpubh-09-766162-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/8718442/a7cda004c3f4/fpubh-09-766162-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/8718442/d1524ab8c9c6/fpubh-09-766162-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/8718442/6ad2aac9b5a1/fpubh-09-766162-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/8718442/2ae1b0bba206/fpubh-09-766162-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/8718442/e0cbaf18c3f8/fpubh-09-766162-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/8718442/59ce852244dd/fpubh-09-766162-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/8718442/1a635e644b67/fpubh-09-766162-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/8718442/5fc9b894b3d2/fpubh-09-766162-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/8718442/a7cda004c3f4/fpubh-09-766162-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/8718442/d1524ab8c9c6/fpubh-09-766162-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/8718442/6ad2aac9b5a1/fpubh-09-766162-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/8718442/2ae1b0bba206/fpubh-09-766162-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/8718442/e0cbaf18c3f8/fpubh-09-766162-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/8718442/59ce852244dd/fpubh-09-766162-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1b/8718442/1a635e644b67/fpubh-09-766162-g0008.jpg

相似文献

1
A Cross-Sectional Survey to Assess Biorisk Management System in Research and Diagnostic Laboratories in Khyber Pakhtunkhwa, Pakistan.巴基斯坦开伯尔-普赫图赫瓦省研究和诊断实验室生物风险管理系统的横断面调查。
Front Public Health. 2021 Dec 17;9:766162. doi: 10.3389/fpubh.2021.766162. eCollection 2021.
2
Assessment of biosafety implementation in clinical diagnostic laboratories in Pakistan during the COVID-19 pandemic.新冠疫情期间巴基斯坦临床诊断实验室生物安全实施情况评估
J Biosaf Biosecur. 2022 Jun;4(1):43-49. doi: 10.1016/j.jobb.2022.01.001. Epub 2022 Jan 19.
3
[Biorisk Management for Clinical Diagnostic Laboratories].临床诊断实验室的生物风险管控
Rinsho Byori. 2016 Nov;64(11):1279-1289.
4
Biosafety and biosecurity measures: management of biosafety level 3 facilities.生物安全和生物安保措施:三级生物安全设施的管理。
Int J Antimicrob Agents. 2010 Nov;36 Suppl 1:S70-4. doi: 10.1016/j.ijantimicag.2010.06.026. Epub 2010 Aug 30.
5
Effectiveness of international virtual training on biorisk management in the context of COVID-19.新冠疫情背景下国际虚拟培训在生物风险管理方面的效果。
Front Public Health. 2022 Oct 11;10:888097. doi: 10.3389/fpubh.2022.888097. eCollection 2022.
6
Strengthening Biorisk Management Capacities in Burkina Faso: Contribution of the Global Health Security Agenda.加强布基纳法索的生物风险管控能力:全球卫生安全议程的贡献
Health Secur. 2022 Nov-Dec;20(6):479-487. doi: 10.1089/hs.2019.0069. Epub 2022 Nov 18.
7
A Mentorship Program to Develop Biorisk Manuals for Laboratories in Pakistan.为巴基斯坦实验室编写生物风险手册的指导计划。
Appl Biosaf. 2022 Dec 1;27(4):219-224. doi: 10.1089/apb.2022.0007. Epub 2022 Nov 23.
8
Harmonization of European laboratory response networks by implementing CWA 15793: use of a gap analysis and an "insider" exercise as tools.通过实施CWA 15793协调欧洲实验室应对网络:使用差距分析和“内部人员”演练作为工具
Biosecur Bioterror. 2013 Sep;11 Suppl 1:S36-44. doi: 10.1089/bsp.2013.0020.
9
Implementing an Organizational Culture of Biosafety and Biosecurity in the ŞAP Institute.在ŞAP研究所实施生物安全和生物安保的组织文化。
Health Secur. 2024 Aug;22(4):271-280. doi: 10.1089/hs.2023.0044. Epub 2024 May 30.
10
A Multilingual Tool for Standardized Laboratory Biosafety and Biosecurity Assessment and Monitoring.一种用于标准化实验室生物安全和生物安保评估和监测的多语言工具。
Health Secur. 2022 Nov-Dec;20(6):488-496. doi: 10.1089/hs.2022.0030. Epub 2022 Nov 16.

引用本文的文献

1
A Mentorship Program to Develop Biorisk Manuals for Laboratories in Pakistan.为巴基斯坦实验室编写生物风险手册的指导计划。
Appl Biosaf. 2022 Dec 1;27(4):219-224. doi: 10.1089/apb.2022.0007. Epub 2022 Nov 23.

本文引用的文献

1
Improving Biosecurity in Pakistan: Current Efforts, Challenges, and Recommendations on a Multidimensional Management Strategy.加强巴基斯坦的生物安全:多维管理策略的当前努力、挑战和建议。
Health Secur. 2021 May-Jun;19(3):254-261. doi: 10.1089/hs.2020.0050. Epub 2021 May 5.
2
A Tool for Assessment of Animal Health Laboratory Safety and Biosecurity: The Safety Module of the Food and Agriculture Organization's Laboratory Mapping Tool.一种动物健康实验室安全与生物安全评估工具:粮农组织实验室绘图工具的安全模块
Trop Med Infect Dis. 2018 Mar 14;3(1):33. doi: 10.3390/tropicalmed3010033.
3
Digitization of the health sector in Pakistan: challenges and opportunities to online health communication: A case study of MARHAM social and mobile media.
巴基斯坦卫生部门的数字化:在线健康传播面临的挑战与机遇——以MARHAM社交和移动媒体为例
Digit Health. 2018 Jul 23;4:2055207618789281. doi: 10.1177/2055207618789281. eCollection 2018 Jan-Dec.
4
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家发病率、患病率以及 195 个国家和地区 1990 年至 2016 年 328 种疾病和伤害导致的残疾年数:2016 年全球疾病负担研究的系统分析。
Lancet. 2017 Sep 16;390(10100):1211-1259. doi: 10.1016/S0140-6736(17)32154-2.
5
Biosafety Initiatives in BMENA Region: Identification of Gaps and Advances.BMENA 地区的生物安全倡议:差距与进展的识别。
Front Public Health. 2016 Mar 24;4:44. doi: 10.3389/fpubh.2016.00044. eCollection 2016.
6
Biological Risks and Laboratory-Acquired Infections: A Reality That Cannot be Ignored in Health Biotechnology.生物风险和实验室获得性感染:健康生物技术中不容忽视的现实。
Front Bioeng Biotechnol. 2015 Apr 28;3:56. doi: 10.3389/fbioe.2015.00056. eCollection 2015.
7
Global Health Security Demands a Strong International Health Regulations Treaty and Leadership From a Highly Resourced World Health Organization.全球卫生安全需要一项强有力的《国际卫生条例》条约以及资源充足的世界卫生组织发挥领导作用。
Disaster Med Public Health Prep. 2015 Oct;9(5):568-80. doi: 10.1017/dmp.2015.26. Epub 2015 Feb 18.
8
Novel dutch self-assessment biosecurity toolkit to identify biorisk gaps and to enhance biorisk awareness.新型荷兰自我评估生物安全工具包,用于识别生物风险差距并提高生物风险意识。
Front Public Health. 2014 Oct 20;2:197. doi: 10.3389/fpubh.2014.00197. eCollection 2014.
9
Biosafety, biosecurity and internationally mandated regulatory regimes: compliance mechanisms for education and global health security.生物安全、生物安保与国际强制监管制度:教育及全球卫生安全的合规机制
Med Confl Surviv. 2013 Oct-Dec;29(4):289-321. doi: 10.1080/13623699.2013.841355.
10
Biosafety perspective of clinical laboratory workers: a profile of Pakistan.临床实验室工作人员的生物安全视角:巴基斯坦概况
J Infect Dev Ctries. 2012 Aug 21;6(8):611-9. doi: 10.3855/jidc.2236.